NASH Clinical Trial
Official title:
A Multi-Center, Randomised, Double-blind, Placebo Controlled Phase II Clinical Study of Chiglitazar in Patients With Nonalcoholic Steatohepatitis Accompanied by Elevated Triglycerides and Insulin Resistance
The study is to evaluate the efficacy and safety of chiglitazar monotherapy in patients with non-clcoholic steatohepatitis (NASH).
The study is a non-invasive exploratory phase II trial in patients who were clinically diagnosed as non-alcoholic steatohepatitis (NASH) with liver fibrosis accompanied by elevated triglycerides (TG) and insulin resistance. The efficacy and safety of chiglitazar tablets 48mg and 64mg will be compared with placebo in the 18-week-treament. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05479721 -
LITMUS Imaging Study
|
||
| Recruiting |
NCT06308757 -
Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis
|
N/A | |
| Completed |
NCT02923154 -
Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
|
Phase 2 | |
| Withdrawn |
NCT03980912 -
Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy
|
||
| Terminated |
NCT04565717 -
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)
|
Phase 1 | |
| Not yet recruiting |
NCT05935488 -
Early Liver Disease Breath Detection
|
||
| Recruiting |
NCT04302051 -
Assessment of Fatty Liver With Thermo-acoustic Device
|
||
| Recruiting |
NCT05327127 -
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
|
Phase 2 | |
| Completed |
NCT06348706 -
Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes
|
Phase 3 | |
| Active, not recruiting |
NCT06315361 -
DIAbetes and NAFLD
|
||
| Completed |
NCT03187496 -
Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.
|
Phase 1 | |
| Not yet recruiting |
NCT06364462 -
Precise Evaluation Criteria for Histological Regression of NASH Fibrosis
|
||
| Recruiting |
NCT04442334 -
The European NAFLD Registry
|
||
| Recruiting |
NCT06338969 -
The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis
|
N/A | |
| Active, not recruiting |
NCT05669677 -
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
|
||
| Not yet recruiting |
NCT04783116 -
Plant Stanols and Liver Inflammation in Overweight and Obese Children
|
N/A | |
| Recruiting |
NCT06193629 -
A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar
|
N/A | |
| Completed |
NCT04006145 -
A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH
|
Phase 2 | |
| Recruiting |
NCT04232293 -
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
|
N/A | |
| Not yet recruiting |
NCT04925362 -
THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)
|
N/A |